Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Celiac Disease Market Growth in 2025?

In the last few years, the market size for celiac disease has seen significant expansion. It is projected to accelerate from $0.71 billion in 2024 to $0.78 billion in 2025, marking a compound annual growth rate (CAGR) of 10.4%. This growth during the historical period is due to several factors, including a surge in celiac disease incidences, heightened knowledge about disorders linked to gluten, more funding allocated for autoimmune diseases research, the rise in food allergy cases and sensitivities, and an increased focus on health among consumers.

What Is the Forecast for the Celiac Disease Market Size Through 2029?

The market for celiac disease is set for swift expansion in the upcoming years, with projections suggesting it will surge to $1.15 billion by 2029, with a compound annual growth rate (CAGR) of 10.1%. Factors contributing to this predicted growth in the forecast period are the escalating demand for personalized medicine, strengthened healthcare facilities, increased needs for dietetic counseling services, and higher rates of pediatric diagnosis. Other proactive steps towards early detection and prevention are also key contributors. Noteworthy trends for the forecast period comprise the accessibility of diagnostic tests, advancements in the field of genetic testing, enhanced primary care screening protocols, cutting-edge innovations in ELISA and serological testing, and the embrace of non-evasive diagnostic methodologies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24497&type=smp

What are the Key Market Players in Celiac Disease Market and How They’re Evolving?

Major companies operating in the celiac disease market are Pfizer Inc., Sanofi SA, Novartis AG, Takeda Pharmaceutical Company Ltd., Chugai Pharmaceutical Co. Ltd., Dr Falk Pharma GmbH, Theriva Biologics Inc., Equillium Inc., Immunic Inc., Barinthus Biotherapeutics Plc, Allero Therapeutics, Anokion SA, Mozart Therapeutics, ImmunogenX, Topas Therapeutics GmbH, Parvus Therapeutics Inc., AMYRA Biotech AG, Provention Limited, Precigen Inc., Zedira GmbH, AnTolRx Inc., Nemysis Ltd., Entero Therapeutics Inc.

What Are the Primary Growth Drivers in the Celiac Disease Market?

The expansion of the celiac disease market is anticipated to be propelled by the rise in personalized medicine. Personalized healthcare, which individualizes medical treatment based on one’s genetic makeup, environment, and lifestyle, is at the heart of this. The surge in genetic testing availability, which makes for more precise diagnoses and treatments tailored to each patient, is heightening the appeal of personalized medicine. It aids in the treatment of celiac disease by facilitating the exact identification of genetic markers and personal immune responses, resulting in more specific and effective management techniques for each patient. For example, the US-based nonprofit organization, the Personalized Medicine Coalition, reported in February 2024 that the FDA sanctioned 16 personalized therapies aimed at rare diseases in 2023, an increase from the 6 that were approved in 2022. Therefore, the rise in personalized medicine is set to stimulate the expansion of the celiac disease market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24497&type=smp

What Are the Leading Segments in the Global Celiac Disease Industry?

The celiac disease market covered in this report is segmented –

1) By Treatment: Infliximab, Larazotide Acetate, Gluten Free Diet, Other Treatments

2) By Route Of Administration: Oral, Parenteral

3) By End Users: Hospitals, Homecare, Other End-Users

Subsegments:

1) By Infliximab: Biosimilar Infliximab, Branded Infliximab, Intravenous Administration, Hospital-Based Usage, Off-Label Use In Refractory Celiac Disease,

2) By Larazotide Acetate: Clinical Trial Phase Products, Oral Capsule Formulation, Adult Celiac Patients, Pediatric Investigational Use, Monotherapy And Combination Therapy

3) By Gluten Free Diet: Packaged Gluten-Free Foods, Gluten-Free Bakery Products, Gluten-Free Snacks, Gluten-Free Nutritional Supplements, Gluten-Free Beverages

4) By Other Treatments: Corticosteroids, Immunosuppressive Drugs, Enzyme Therapies, Monoclonal Antibodies, Probiotics And Microbiome Modulators

What Are the Key Market Trends in the Celiac Disease Industry?

Leading corporations in the celiac disease sector are making strides in producing sophisticated solutions like anti-interleukin-15 (IL-15) antibodies, designed to prevent tissue harm by curbing the heightened activity of the immune cells. These antibodies are specialized proteins that hinder the IL-15 cytokine’s functionality, thereby keeping a check on the immune activity and inflammation. Notably, in May 2025, Teva Pharmaceutical Industries, a pharmaceutical firm based in Israel, reported that the U.S. Food and Drug Administration had allocated Fast Track status to its under-investigation anti-IL-15 antibody, TEV-53408. This investigational monoclonal antibody, targeted for individuals suffering from celiac disease who persist with a gluten-free diet, acts by obstructing IL-15, an element instrumental in igniting the immune response consequential in intestinal damage in sufferers of celiac disease. Currently, the treatment’s safety and effectiveness are under scrutiny in a Phase 2a clinical trial.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/celiac-disease-global-market-report

What Is the Regional Outlook for the Celiac Disease Market?

North America was the largest region in the celiac disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24497

This Report Delivers Insight On:

1. How big is the celiac disease market, and how is it changing globally?

2. Who are the major companies in the celiac disease market, and how are they performing?

3. What are the key opportunities and risks in the celiac disease market right now?

4. Which products or customer segments are growing the most in the celiac disease market?

5. What factors are helping or slowing down the growth of the celiac disease market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model